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A B S T R A C T   
Background. The COVID-19 pandemic has given rise to stress worldwide, especially in vulnerable people like 
those suffering from mental illness. This study aims to investigate the psychological distress perceived by a 
cohort of patients with Major Depressive Disorder (MDD) or Bipolar Disorder (BD) after a seven-week period of 
lockdown measures, and to analyze serum 25-hydroxyvitamin D [25(OH)D] levels as a potential predictor of 
distress severity. 
Methods. Fifty-nine remitted MDD and fifty-three euthymic BD patients were enrolled. An online dedicated 
survey was administered to obtain lockdown-related information and to evaluate COVID-19 related distress by 
using the Kessler 10 Psychological Distress Scale (K10). Patients’ medical records were reviewed to collect 
sociodemographic and clinical data, including serum 25(OH)D levels dosed in the three months preceding the 
outbreak. A multivariate general linear model was adopted to test the effect of factors of interest on psychological 
distress. 
Results. In our sample (n = 112), 29 subjects (25.9 %) reported no likelihood of psychological distress, 
whereas 35 (31.2 %) and 48 (42.9 %) displayed mild and moderate-to-severe likelihood of psychological distress, 
respectively. Low serum 25(OH)D levels (p = 0.005) and MDD diagnosis (p = 0.001) specifically predicted the 
severity of psychological distress. Living alone during the lockdown, a longer duration of illness, and smoking 
habits were more frequently detected in subjects with COVID-19 related distress. 
Conclusions. Low serum 25(OH)D levels and MDD diagnosis predicted an increased vulnerability to the 
stressful impact of the COVID-19 outbreak. Our results suggest that vitamin D may represent a biological factor 
mediating the psychological response to stress in individuals with affective disorders and provide further insight 
into tailoring intervention strategies.   
1. Introduction 
The ongoing COVID-19 pandemic and related containment measures 
imposed by governments, including self-isolation and social distancing, 
have largely affected mental health worldwide. Preliminary data from 
different countries highlighted increased levels of psychological distress 
among the general population (Vindegaard and Eriksen Benros, 2020; 
Xiong et al., 2020). Subjects with mental disorders showed to be even 
more consistently influenced by the COVID-19 epidemic and lockdown 
measures, reporting significant worsening of the clinical conditions and 
potentially higher risk for recurrence (Sani et al., 2020; Vindegaard and 
Eriksen Benros, 2020; Yao et al., 2020). 
Vitamin D is a neuroactive steroid involved in brain development, 
synaptic plasticity, neuroprotection, neurotransmission, and neuro-
immunomodulation (Groves et al., 2014). Vitamin D metabolites have 
been shown to protect neural integrity in brain areas implicated in the 
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pathophysiology of stress response and mood regulation, such as the 
prefrontal cortex, amygdala, and hippocampus (Groves et al., 2014; 
Wimalawansa, 2019). Also, vitamin D appears to play a role in the 
modulation of neuroinflammatory pathways, whose dysfunctions have 
been linked to both altered stress response and depression (Berk et al., 
2013; Wimalawansa, 2019). 
A growing body of literature suggests that vitamin D deficiency may 
represent an underlying vulnerability factor for several psychiatric dis-
turbances, including major depressive disorder (MDD) and bipolar dis-
order (BD) (Anglin et al., 2013; Milaneschi et al., 2014; Patrick and 
Ames, 2015). Accordingly, low levels of vitamin D have been found in 
both MDD and BD patients (Belzeaux et al., 2015; Boerman et al., 2016; 
Cuomo et al., 2019), although the nature of this association as well as 
clinical and therapeutic implications are still debated (Jamilian et al., 
2019; Okereke et al., 2020). 
The link between hypovitaminosis D and response to stressful events, 
including possible future mental health outcomes, is less investigated. 
However, low serum levels of vitamin D have been associated with 
increased stress perception and worse clinical outcomes in response to 
traumatic events (Gwon et al., 2016; Chen et al., 2020; Terock et al., 
2020). 
To the best of our knowledge, no previous study on individuals with 
mood disorders has investigated the association between serum levels of 
25-hydroxyvitamin D [25(OH)D] and psychological response to such a 
stressful large-scale event, like the ongoing COVID-19 outbreak. 
Therefore, we aimed to evaluate the psychological impact of the 
pandemic in a cohort of remitted patients affected by MDD or BD, and to 
analyze serum 25(OH)D levels as a potential predictive factor influ-
encing the extent of psychological burden. We hypothesized that low 
serum 25(OH)D levels may predict increased psychological distress 
during the COVID-19 outbreak. 
2. Materials and methods 
2.1. Participants and procedure 
Participants were enrolled among outpatients regularly referring to 
the Psychiatric Unit of the Fondazione Policlinico Universitario Agostino 
Gemelli IRCCS, Università Cattolica del Sacro Cuore of Rome. Inclusion 
criteria were: age 18–70; being Caucasian; DSM-5 diagnosis of MDD or 
BD (type I and II); euthymia for at least six months (Hamilton Depression 
Rating Scale - HDRS < 8; Young Mania Rating Scale - YMRS < 6); serum 
25(OH)D levels measured between December 2019 and February 2020. 
To mitigate factors affecting 25(OH)D deficiency, we excluded in-
dividuals with chronic liver or renal diseases, severe conditions of 
malabsorption or malnutrition, with current alcohol or substance abuse, 
or taking vitamin D supplements. All enrolled patients had been under 
stable psychopharmacological treatment for at least six months and 
were routinely assessed through psychometric tests (including HDRS 
and YMRS) at baseline and follow-up visits. The final sample of 112 
subjects may represent about 40 % of outpatients with mood disorders 
consecutively referring to our Unit during the three-month timeframe. 
Participants were assessed through an on-line survey between April 
27th and April 29th, 2020. This time-lapse was chosen to evaluate sub-
jects’ distress after a seven-week period of strict lockdown measures 
enforced by the Italian Government across the whole national territory 
(Decree of 9th March, 2020). 
The survey was anonymous and data confidentiality was assured 
according to the European Survey Research Association (ESRA) guide-
lines. All participants completed the questionnaire online via EUSurvey. 
The study has been approved by the local Ethics Committee. 
2.2. Data collection and psychometric assessment 
A dedicated, self-report on-line questionnaire was administered to 
collect information on the patients’ lockdown conditions (living alone, 
changes in work routines, working on the frontline), and to carry out the 
psychometric assessment. Sociodemographic (age, gender, educational 
level, occupation, marital status) and clinical data (psychiatric diag-
nosis, age of onset, duration of illness, hospitalizations, suicide attempts, 
current psychopharmacological treatment, lifetime history of chronic 
diseases, family history of psychiatric disorders, Body Mass Index (BMI), 
smoking habits, serum 25(OH)D levels) were extracted from the pa-
tients’ medical records. 
The Italian version of the Kessler 10 Psychological Distress Scale 
(K10) (Carrà et al., 2011) was used to assess the psychological impact of 
the COVID-19 outbreak. K10 is a 10-item questionnaire, based on a 
5-point Likert scale ranging from 1 (never) to 5 (always), providing a 
global measure of distress, anxiety and depressive symptoms experi-
enced in the most recent 4-week period. The total score may range be-
tween 10 and 50, and high scores indicate high levels of psychological 
distress. Consistently with previous validation studies (Andrews and 
Slade, 2001), we adopted the cutoff scores of >19 and >24 to detect the 
likelihood of mild and moderate-to-severe psychological distress, 
respectively. 
2.3. Assessment of serum 25(OH)D levels and potential confounding 
factors 
We retrospectively evaluated serum 25(OH)D concentrations in 112 
patients. All 25(OH)D samples had been analyzed using chem-
iluminescence immunoassay (CLIA) and had been measured in nano-
grams per milliliter (ng/mL). As reported by the US Endocrine Society 
Clinical Practice Guidelines, vitamin D sufficiency is defined by serum 
levels of 25(OH)D ranging between 30 and 100 ng/mL (Holick et al., 
2011). Potential confounding factors associated with serum vitamin D 
levels (age, BMI, smoking habits, medical comorbidities, and current 
pharmacotherapy) were included in the statistical analysis to control for 
possible biases. Further potential confounders, such as seasonality of 
blood sampling and sunlight exposure, were avoided by collecting 25 
(OH)D samples within the same timeframe. 
2.4. Statistical analysis 
To fit our aims, we have adopted a dual approach considering both 
K10 cutoffs and continuous total scores. In the first part of the analysis, 
we divided the sample into three groups according to the K10 cutoffs: 1) 
subjects without likelihood of psychological distress, 2) subjects with 
likelihood of mild psychological distress, and 3) subjects with likelihood 
of moderate-to-severe psychological distress. The one-way analysis of 
variance for continuous measures (ANOVA) and the chi-square test for 
nominal variables were used to compare factors of interest (socio-
demographic characteristics, information on lockdown conditions, 
clinical data and serum 25(OH)D levels) in the three groups. The level of 
significance was set at p < 0.05. 
In the second part of the analysis, a multivariate general linear model 
was adopted to evaluate the impact of risk factors on the gradient of 
psychological distress severity, considered as a continuum according to 
the K10 total scores. Multiple linear regression was used to predict the 
severity of psychological distress based on factors significantly associ-
ated with mild or moderate-to-severe psychological distress in univari-
ate/bivariate analysis. Possible multicollinearity between the variables 
of interest was tested through the variance inflation factor (VIF) in-
dicators. Statistical analysis was performed using SPSS v. 25 (IBM Corp., 
USA). 
3. Results 
In our sample (n = 112), 29 subjects (25.9 %) reported no likelihood 
of psychological distress, whereas 35 (31.2 %) and 48 (42.9 %) dis-
played mild and moderate-to-severe likelihood of psychological distress, 
respectively (overall mean K10 total scores = 22.5 ± 6.04). Results of 
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the univariate/bivariate analysis of sociodemographic characteristics, 
information on lockdown conditions and medical status, including 
serum 25(OH)D levels, are summarized in Table 1. The three groups 
differed in age, occupation, living alone during quarantine, psychiatric 
diagnosis, duration of illness, smoking habits, and serum 25(OH)D 
levels. Specifically, subjects displaying insufficient levels of 25(OH)D 
were 14 (15.9 %), 32 (36.4 %), and 42 (47.7 %) within each group, 
respectively. According to the multivariate general linear model, low 
serum 25(OH)D levels and MDD diagnosis significantly predicted psy-
chological distress severity (Table 2, Supplementary Figure 1). In 
particular, serum 25(OH)D levels were inversely associated with psy-
chological distress severity. There was no significant multicollinearity in 
the model, as indicated by the fact that the VIF of all variables of interest 
was < 2. 
4. Discussion 
The psychological impact of the COVID-19 outbreak has rapidly 
become an issue of global interest, with an increasing concern over 
vulnerable people like those affected by mental health conditions. 
Hence, we conducted a survey to investigate the occurrence of psycho-
logical distress during the ongoing pandemic in a cohort of patients with 
mood disorders. Our findings indicate that 74 % of the sample was 
perceiving a form of psychological distress at the time of the study, 
nearly twice as much as what reported by K10 results among the Italian 
general population during an early phase of the epidemic (Moccia et al., 
2020). Similarly, current evidence endorses the severity of the psycho-
logical impact of the COVID-19 outbreak among patients with affective 
disorders showing that post-traumatic stress, anxiety, and depressive 
symptoms are significantly higher than in healthy controls (Fiorillo and 
Gorwood, 2020; González-Blanco et al., 2020; Hao et al., 2020). 
In our sample, an MDD diagnosis predicted a more severe 
Table 1 
Sociodemographic data, information on lockdown conditions, and clinical characteristics of the sample.  






χ2 or F df p         
Overall 112 29 (25.9) 35 (31.2) 48 (42.9)    
Sociodemographic characteristics 
Age (years) 47.2 ± 16.4 42.6 ± 13.0 45.4 ± 16.4 51.4 ± 17.6 3.200 2 0.047 
Gender     0.829 2 0.661 
Male 52 (46.4) 15 (51.7) 17 (48.6) 20 (41.7)    
Female 60 (53.6) 14 (48.3) 18 (51.4) 28 (58.3)    
Educational level (years) 14.6 ± 2.9 15.1 ± 3.1 14.0 ± 2.7 14.7 ± 3.0 1.159 2 0.320 
Occupation     6.40 2 0.041 
Employed 75 (67) 23 (79.3) 26 (74.3) 26 (54.2)    
Unemployed 37 (33) 6 (20.7) 9 (25.7) 22 (45.8)    
Marital status     1.58 2 0.454 
Married 35 (31.2) 10 (34.5) 13 (37.1) 12 (25.0)    
Unmarried 77 (68.8) 19 (65.5) 22 (62.9) 36 (75.0)    
Information on lockdown conditions 
Living alone 29 (25.9) 5 (16.7) 4 (11.4) 20 (42.6) 10.9 2 0.004 
Changes in work routines 47 (42.0) 16 (55.2) 14 (38.9) 17 (36.2) 3.03 2 0.220 
Working on the frontline 2 (1.8) 0 (0.0) 0 (0.0) 2 (4.3) 2.85 2 0.240 
Medical status 
Psychiatric diagnosis     6.60 2 0.037 
Major Depressive Disorder 59 (52.7) 10 (34.5) 18 (51.4) 31 (64.6)    
Bipolar Disorder 53 (47.3) 19 (65.5) 17 (48.6) 17 (35.4)    
Age of onset (years) 37.0 ± 14.4 34.3 ± 9.7 37.2 ± 15.2 38.4 ± 16.1 1.056 2 0.353 
Duration of illness (years) 9.9 ± 8.8 7.8 ± 6.4 8.2 ± 7.6 12.4 ± 10.2 3.247 2 0.045 
Hospitalizations 30 (26.8) 9 (31.0) 5 (14.3) 16 (33.3) 4.10 2 0.128 
Suicide attempts 7 (6.2) 2 (6.9) 2 (5.7) 3 (6.3) 0.0378 2 0.981 
Current psychopharmacological treatment 
Antidepressants 77 (68.8) 19 (65.5) 24 (68.6) 34 (70.8) 0.239 2 0.888 
Mood stabilizers 70 (62.5) 21 (72.4) 22 (62.9) 27 (56.3) 2.02 2 0.365 
Antipsychotics 62 (55.4) 15 (51.7) 16 (45.7) 31 (64.6) 3.13 2 0.210 
Sedative-hypnotics 20 (17.8) 2 (6.9) 7 (20.0) 11 (22.9) 3.32 2 0.190 
Lifetime history of chronic diseases 20 (17.8) 4 (13.8) 4 (11.4) 12 (25.0) 3.18 2 0.204 
Family history of psychiatric 
disorders 
39 (34.8) 9 (31.0) 12 (34.3) 18 (37.5) 0.431 2 0.806 
BMI 24.6 ± 4.5 24.8 ± 4.2 23.8 ± 3.8 25.1 ± 5.1 0.843 2 0.435 
Smoking 41 (36.6) 14 (48.3) 16 (45.7) 11 (22.9) 6.45 2 0.040 
Serum 25(OH)D levels 21.6 ± 12.2 28.2 ± 12.6 19.9 ± 10.9 18.8 ± 11.6 5.709 2 0.005 
Psychometric assessment        
K10 results 22.5 ± 6.04 14.9 ± 2.7 22.5 ± 1.5 27.1 ± 4.9 125.19 2 <0.001 
Significant results in bold characters. Abbreviations: M, mean; SD, standard deviation; df, degrees of freedom; χ2, chi-squared test; p, statistical significance; F, value of 
variance of the group means; BMI, body mass index; 25(OH)D, 25-hydroxyvitamin D; K10, Kessler 10 Psychological Distress Scale. 
Table 2 
Linear Regression.     
95 % Confidence 
Interval   
Predictors Estimate SE Lower Upper t p 
Age − 0.0158 0.0405 − 0.2586 0.1736 − 0.390 0.697 
Occupation − 2.2633 1.2185 − 0.3588 0.0118 − 1.857 0.066 
Living alone 1.9343 1.2471 − 0.0387 0.3164 1.551 0.124 
Psychiatric 
diagnosis 
− 3.7815 1.1184 − 0.4900 − 0.1276 − 3.381 0.001 
Duration of 
illness 
0.0839 0.0710 − 0.0827 0.3257 1.181 0.241 




− 0.1265 0.0443 − 0.4271 − 0.0769 − 2.855 0.005        
Significant results in bold characters. Abbreviations: SE, Size Effect; t, t statistic; 
p, statistical significance; 25(OH)D, 25-hydroxyvitamin D. 
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psychological distress during the COVID-19 pandemic, compared to BD. 
Repeated evidence demonstrated alterations of the neuroendocrinal 
stress response in MDD patients, namely hyperactivity of the hypo-
thalamic–pituitary–adrenal (HPA) axis, which might represent a bio-
logical risk factor for sensitization to subsequent stresses (Heim et al., 
2008). In fact, MDD patients seem to be at risk for greater psychological 
stress reactivity and for experiencing a recurrence when facing stressors, 
with a heightened sensitivity to social stress, especially if they have been 
exposed to traumatic experiences early in life (Stroud et al., 2011; van 
Winkel et al., 2015; Kim et al., 2020). Also, some reports suggest that 
remitted MDD patients, compared to euthymic BD, may perform poorer 
adaptive behaviors in the face of adverse events, that might impact on 
stress perception (Coulston et al., 2013). 
Our findings indicate that low 25-hydroxyvitamin D serum levels 
were significantly associated with higher psychological distress in pa-
tients with mood disorders during the COVID-19 outbreak. Similar re-
sults were observed by Chen et al., who recently found a significant 
correlation between lower serum 25(OH)D and increased measures of 
psychosocial stress and poorer mental health in a large sample of young 
adults (Chen et al., 2020). However, further studies should aim at better 
clarifying this relationship. 
The biological mechanisms through which vitamin D might modu-
late psychological distress are still unclear and require further in-
vestigations. Some evidence suggests that vitamin D may act as a 
neuroprotective agent from oxidative-stress damages and stress-induced 
inflammatory effects on the brain in rodent models, and that vitamin D 
deficiency exacerbates behavioral impairments caused by stress (Berk 
et al., 2013; Jiang et al., 2013; Groves et al., 2017). Interestingly, af-
fective disorders are associated with chronic, low-grade inflammatory 
response, as well as with increased oxidative stress, which might 
conjointly contribute to neuro-progression (Berk et al., 2013). As a 
neuroactive hormone, vitamin D is also implicated in the metabolic 
pathways of the monoaminergic system, including serotonin and 
dopamine. The effects of stress seem to reduce brain monoamine syn-
thesis and release, which may ultimately lead to increased anxious or 
depressive behavior (Lee and Han, 2019). Thus, combined stressful 
events and inadequate 25(OH)D levels may promote to some extent the 
onset of psychiatric symptoms and exacerbate mental diseases, partic-
ularly mood disorders (Patrick and Ames, 2015; Sedaghat et al., 2019). 
Several studies showed some beneficial effects of vitamin D supple-
mentation in clinically depressed subjects with hypovitaminosis D 
(Parker et al., 2017; Jamilian et al., 2019). However, a large longitudinal 
randomized trial has recently shown that treatment with vitamin D3, 
compared with placebo, does not result in a significant difference in the 
incidence and recurrence of depression or of clinically relevant 
depressive symptoms, nor in a change in mood scores (Okereke et al., 
2020). 
Some limitations to the generalizability of our results must be 
acknowledged. First, the study has a cross-sectional design and lacks 
longitudinal follow-up. Therefore, causality between 25(OH)D levels 
and stress response in patients with affective disorders cannot be un-
equivocally determined, and prospective studies with a larger sample 
size are needed to unravel causal inferences. Second, although multiple 
potential confounders were accurately investigated to estimate the 
correlation between vitamin D levels and psychological distress, addi-
tional confounding factors have not been collected (e.g., socio-economic 
status, physical activity, dietary habits, prolactin levels and other pa-
rameters of the phosphocalcic metabolism). Finally, the reliability of 
self-administered questionnaires may be partially biased. 
5. Conclusions 
Our data show that major depression and low levels of vitamin D may 
predict a higher load of psychological distress in patients affected by 
mood disorders when facing a stressful event. Future research should 
aim to determine whether vitamin D may be physiologically involved in 
increased vulnerability to stress, revealing deeper relationships between 
systemic inflammation, monoaminergic modulation, and serum 25(OH) 
D levels. To this regard, potential benefits of vitamin D supplementation 
require further investigations. Mental health needs associated with the 
pandemic must be rapidly addressed, with a special focus on vulnerable 
people like those with mental disorders. 
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